Non-O Blood Group Is Associated with High Thrombus Burden and Poor Short- and Long-Term Prognosis in ST-Segment Elevation Myocardial Infarction Patients
Abstract Introduction: This study investigated how non-O blood groups relate to thrombus burden (TB) and prognosis in ST-segment elevation myocardial infarction (STEMI) patients, aiming to shed light on their association with thrombotic complications in cardiovascular diseases. Methods: Retrospectiv...
Gespeichert in:
| Veröffentlicht in: | Medical Principles and Practice 2024-10, Vol.33 (5), p.431-440 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 440 |
|---|---|
| container_issue | 5 |
| container_start_page | 431 |
| container_title | Medical Principles and Practice |
| container_volume | 33 |
| creator | Toprak, Kenan Kaplangöray, Mustafa Omar, Muhammed Bahadır Dursun, Ayten Toprak, İbrahim Halil Acar, Osman Demirbağ, Recep |
| description | Abstract
Introduction: This study investigated how non-O blood groups relate to thrombus burden (TB) and prognosis in ST-segment elevation myocardial infarction (STEMI) patients, aiming to shed light on their association with thrombotic complications in cardiovascular diseases. Methods: Retrospectively, 1,180 STEMI patients undergoing primary percutaneous coronary intervention were included. The study population was divided into groups according to TB status and the groups were compared in terms of basic clinical characteristics, laboratory parameters and ABO blood group types. In addition, short-term (30 days) and long-term (12 months) clinical outcomes were assessed to evaluate the prognostic implications. Results: The analysis revealed a significant association between non-O blood groups and increased TB in STEMI patients (p = 0.001). Non-O blood group was independently associated with high TB (OR: 1.726, 95% confidence interval [CI]: 1.279–2.330, p < 0.001). Additionally, patients with non-O blood groups had higher short and long-term mortality rates (hazard ratio [HR]: 2.480, 95% CI: 1.361–4.520, p = 0.003; HR: 2.347, 95% CI: 1.433–3.844, p = 0.001; respectively). Conclusions: This study emphasizes the significance of the ABO blood group system in STEMI outcomes, associating non-O blood groups with higher TB and poorer clinical outcomes. While proposing personalized treatment strategies based on blood group status to improve reperfusion interventions and outcomes, additional trials are needed to comprehensively evaluate their impact.
HighlightsNon-O blood groups in ST-segment elevation myocardial infarction (STEMI) patients are linked to higher thrombus burden, suggesting implications for reperfusion interventions.Non-O blood group patients have higher mortality rates, stressing blood group’s importance in STEMI care.Non-O blood group independently predicts high thrombus burden, highlighting its role in STEMI outcomes.This study underscores customizing treatment based on blood group for better outcomes in reperfusion interventions. |
| doi_str_mv | 10.1159/000538777 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000538777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A811729190</galeid><sourcerecordid>A811729190</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-2f339365a807fd6c3b4ef0e6286e9a51972df6f75b8b4897fed257b20ea1240a3</originalsourceid><addsrcrecordid>eNptksFu1DAQhiMEoqVw4I6QpV7gkGLHcZycqm1V2pW2dKVdzpYT24lL4lnspKhvwuPiNmUFCPlge_5v_pmRJkneEnxCCKs-YYwZLTnnz5JDkmc0xYSR5_GNCUk54-QgeRXCbcRKSvHL5ICWBWEFKw-Tn1_ApTforAdQ6NLDtEPLgBYhQGPlqBX6YccOXdm2Q9vOw1BPAZ1NXmmHpFNoDeDRpgM_po__Fbg23Wo_oLWH1kGwAVmHNtt0o9tBuxFd9PpOjhYcur6HRnplZY-WzkjfPEbXUYxceJ28MLIP-s3TfZR8_XyxPb9KVzeXy_PFKm1ygsc0M5RWtGCyxNyooqF1rg3WRVYWupKMVDxTpjCc1WWdlxU3WmWM1xnWkmQ5lvQoOZ19d1M9aNXE2l72YuftIP29AGnF34qznWjhThCSF7jMcXT48OTg4fukwygGGxrd99JpmIKgmFYZpTkvInr8D3oLk3dxPkGjHy94TlmkTmaqlb0W1hmIhZt4lB5sA04bG-OLkhCeVaR66ODjnNB4CMFrs2-fYPGwIWK_IZF9_-e8e_L3SkTg3Qx8k77Vfg_s84__K1-v1zMhdsrQX5lNy08</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3114767435</pqid></control><display><type>article</type><title>Non-O Blood Group Is Associated with High Thrombus Burden and Poor Short- and Long-Term Prognosis in ST-Segment Elevation Myocardial Infarction Patients</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed</source><source>EZB Electronic Journals Library</source><source>Karger Open Access Journals</source><creator>Toprak, Kenan ; Kaplangöray, Mustafa ; Omar, Muhammed Bahadır ; Dursun, Ayten ; Toprak, İbrahim Halil ; Acar, Osman ; Demirbağ, Recep</creator><creatorcontrib>Toprak, Kenan ; Kaplangöray, Mustafa ; Omar, Muhammed Bahadır ; Dursun, Ayten ; Toprak, İbrahim Halil ; Acar, Osman ; Demirbağ, Recep</creatorcontrib><description>Abstract
Introduction: This study investigated how non-O blood groups relate to thrombus burden (TB) and prognosis in ST-segment elevation myocardial infarction (STEMI) patients, aiming to shed light on their association with thrombotic complications in cardiovascular diseases. Methods: Retrospectively, 1,180 STEMI patients undergoing primary percutaneous coronary intervention were included. The study population was divided into groups according to TB status and the groups were compared in terms of basic clinical characteristics, laboratory parameters and ABO blood group types. In addition, short-term (30 days) and long-term (12 months) clinical outcomes were assessed to evaluate the prognostic implications. Results: The analysis revealed a significant association between non-O blood groups and increased TB in STEMI patients (p = 0.001). Non-O blood group was independently associated with high TB (OR: 1.726, 95% confidence interval [CI]: 1.279–2.330, p < 0.001). Additionally, patients with non-O blood groups had higher short and long-term mortality rates (hazard ratio [HR]: 2.480, 95% CI: 1.361–4.520, p = 0.003; HR: 2.347, 95% CI: 1.433–3.844, p = 0.001; respectively). Conclusions: This study emphasizes the significance of the ABO blood group system in STEMI outcomes, associating non-O blood groups with higher TB and poorer clinical outcomes. While proposing personalized treatment strategies based on blood group status to improve reperfusion interventions and outcomes, additional trials are needed to comprehensively evaluate their impact.
HighlightsNon-O blood groups in ST-segment elevation myocardial infarction (STEMI) patients are linked to higher thrombus burden, suggesting implications for reperfusion interventions.Non-O blood group patients have higher mortality rates, stressing blood group’s importance in STEMI care.Non-O blood group independently predicts high thrombus burden, highlighting its role in STEMI outcomes.This study underscores customizing treatment based on blood group for better outcomes in reperfusion interventions.</description><identifier>ISSN: 1011-7571</identifier><identifier>ISSN: 1423-0151</identifier><identifier>EISSN: 1423-0151</identifier><identifier>DOI: 10.1159/000538777</identifier><identifier>PMID: 38615658</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>ABO Blood-Group System ; Aged ; Anticoagulants ; Blood clot ; Blood clots ; Blood groups ; Clinical outcomes ; Diabetes ; Disease ; Female ; Health aspects ; Heart attack ; Heart attacks ; Humans ; Male ; Medical prognosis ; Medical research ; Medicine, Experimental ; Metabolic disorders ; Middle Aged ; Mortality ; Original Paper ; Patients ; Percutaneous Coronary Intervention ; Physiological aspects ; Prognosis ; Retrospective Studies ; ST Elevation Myocardial Infarction - blood ; ST Elevation Myocardial Infarction - mortality ; ST Elevation Myocardial Infarction - surgery ; Statistical analysis ; Thrombosis ; Uric acid ; Veins & arteries</subject><ispartof>Medical Principles and Practice, 2024-10, Vol.33 (5), p.431-440</ispartof><rights>2024 The Author(s). Published by S. Karger AG, Basel</rights><rights>2024 The Author(s). Published by S. Karger AG, Basel.</rights><rights>COPYRIGHT 2024 S. Karger AG</rights><rights>2024 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><rights>2024 The Author(s). Published by S. Karger AG, Basel 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c410t-2f339365a807fd6c3b4ef0e6286e9a51972df6f75b8b4897fed257b20ea1240a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460840/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460840/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27612,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38615658$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toprak, Kenan</creatorcontrib><creatorcontrib>Kaplangöray, Mustafa</creatorcontrib><creatorcontrib>Omar, Muhammed Bahadır</creatorcontrib><creatorcontrib>Dursun, Ayten</creatorcontrib><creatorcontrib>Toprak, İbrahim Halil</creatorcontrib><creatorcontrib>Acar, Osman</creatorcontrib><creatorcontrib>Demirbağ, Recep</creatorcontrib><title>Non-O Blood Group Is Associated with High Thrombus Burden and Poor Short- and Long-Term Prognosis in ST-Segment Elevation Myocardial Infarction Patients</title><title>Medical Principles and Practice</title><addtitle>Med Princ Pract</addtitle><description>Abstract
Introduction: This study investigated how non-O blood groups relate to thrombus burden (TB) and prognosis in ST-segment elevation myocardial infarction (STEMI) patients, aiming to shed light on their association with thrombotic complications in cardiovascular diseases. Methods: Retrospectively, 1,180 STEMI patients undergoing primary percutaneous coronary intervention were included. The study population was divided into groups according to TB status and the groups were compared in terms of basic clinical characteristics, laboratory parameters and ABO blood group types. In addition, short-term (30 days) and long-term (12 months) clinical outcomes were assessed to evaluate the prognostic implications. Results: The analysis revealed a significant association between non-O blood groups and increased TB in STEMI patients (p = 0.001). Non-O blood group was independently associated with high TB (OR: 1.726, 95% confidence interval [CI]: 1.279–2.330, p < 0.001). Additionally, patients with non-O blood groups had higher short and long-term mortality rates (hazard ratio [HR]: 2.480, 95% CI: 1.361–4.520, p = 0.003; HR: 2.347, 95% CI: 1.433–3.844, p = 0.001; respectively). Conclusions: This study emphasizes the significance of the ABO blood group system in STEMI outcomes, associating non-O blood groups with higher TB and poorer clinical outcomes. While proposing personalized treatment strategies based on blood group status to improve reperfusion interventions and outcomes, additional trials are needed to comprehensively evaluate their impact.
HighlightsNon-O blood groups in ST-segment elevation myocardial infarction (STEMI) patients are linked to higher thrombus burden, suggesting implications for reperfusion interventions.Non-O blood group patients have higher mortality rates, stressing blood group’s importance in STEMI care.Non-O blood group independently predicts high thrombus burden, highlighting its role in STEMI outcomes.This study underscores customizing treatment based on blood group for better outcomes in reperfusion interventions.</description><subject>ABO Blood-Group System</subject><subject>Aged</subject><subject>Anticoagulants</subject><subject>Blood clot</subject><subject>Blood clots</subject><subject>Blood groups</subject><subject>Clinical outcomes</subject><subject>Diabetes</subject><subject>Disease</subject><subject>Female</subject><subject>Health aspects</subject><subject>Heart attack</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Metabolic disorders</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Original Paper</subject><subject>Patients</subject><subject>Percutaneous Coronary Intervention</subject><subject>Physiological aspects</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>ST Elevation Myocardial Infarction - blood</subject><subject>ST Elevation Myocardial Infarction - mortality</subject><subject>ST Elevation Myocardial Infarction - surgery</subject><subject>Statistical analysis</subject><subject>Thrombosis</subject><subject>Uric acid</subject><subject>Veins & arteries</subject><issn>1011-7571</issn><issn>1423-0151</issn><issn>1423-0151</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptksFu1DAQhiMEoqVw4I6QpV7gkGLHcZycqm1V2pW2dKVdzpYT24lL4lnspKhvwuPiNmUFCPlge_5v_pmRJkneEnxCCKs-YYwZLTnnz5JDkmc0xYSR5_GNCUk54-QgeRXCbcRKSvHL5ICWBWEFKw-Tn1_ApTforAdQ6NLDtEPLgBYhQGPlqBX6YccOXdm2Q9vOw1BPAZ1NXmmHpFNoDeDRpgM_po__Fbg23Wo_oLWH1kGwAVmHNtt0o9tBuxFd9PpOjhYcur6HRnplZY-WzkjfPEbXUYxceJ28MLIP-s3TfZR8_XyxPb9KVzeXy_PFKm1ygsc0M5RWtGCyxNyooqF1rg3WRVYWupKMVDxTpjCc1WWdlxU3WmWM1xnWkmQ5lvQoOZ19d1M9aNXE2l72YuftIP29AGnF34qznWjhThCSF7jMcXT48OTg4fukwygGGxrd99JpmIKgmFYZpTkvInr8D3oLk3dxPkGjHy94TlmkTmaqlb0W1hmIhZt4lB5sA04bG-OLkhCeVaR66ODjnNB4CMFrs2-fYPGwIWK_IZF9_-e8e_L3SkTg3Qx8k77Vfg_s84__K1-v1zMhdsrQX5lNy08</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Toprak, Kenan</creator><creator>Kaplangöray, Mustafa</creator><creator>Omar, Muhammed Bahadır</creator><creator>Dursun, Ayten</creator><creator>Toprak, İbrahim Halil</creator><creator>Acar, Osman</creator><creator>Demirbağ, Recep</creator><general>S. Karger AG</general><scope>M--</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20241001</creationdate><title>Non-O Blood Group Is Associated with High Thrombus Burden and Poor Short- and Long-Term Prognosis in ST-Segment Elevation Myocardial Infarction Patients</title><author>Toprak, Kenan ; Kaplangöray, Mustafa ; Omar, Muhammed Bahadır ; Dursun, Ayten ; Toprak, İbrahim Halil ; Acar, Osman ; Demirbağ, Recep</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-2f339365a807fd6c3b4ef0e6286e9a51972df6f75b8b4897fed257b20ea1240a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ABO Blood-Group System</topic><topic>Aged</topic><topic>Anticoagulants</topic><topic>Blood clot</topic><topic>Blood clots</topic><topic>Blood groups</topic><topic>Clinical outcomes</topic><topic>Diabetes</topic><topic>Disease</topic><topic>Female</topic><topic>Health aspects</topic><topic>Heart attack</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Metabolic disorders</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Original Paper</topic><topic>Patients</topic><topic>Percutaneous Coronary Intervention</topic><topic>Physiological aspects</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>ST Elevation Myocardial Infarction - blood</topic><topic>ST Elevation Myocardial Infarction - mortality</topic><topic>ST Elevation Myocardial Infarction - surgery</topic><topic>Statistical analysis</topic><topic>Thrombosis</topic><topic>Uric acid</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toprak, Kenan</creatorcontrib><creatorcontrib>Kaplangöray, Mustafa</creatorcontrib><creatorcontrib>Omar, Muhammed Bahadır</creatorcontrib><creatorcontrib>Dursun, Ayten</creatorcontrib><creatorcontrib>Toprak, İbrahim Halil</creatorcontrib><creatorcontrib>Acar, Osman</creatorcontrib><creatorcontrib>Demirbağ, Recep</creatorcontrib><collection>Karger Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile Select</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medical Principles and Practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toprak, Kenan</au><au>Kaplangöray, Mustafa</au><au>Omar, Muhammed Bahadır</au><au>Dursun, Ayten</au><au>Toprak, İbrahim Halil</au><au>Acar, Osman</au><au>Demirbağ, Recep</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-O Blood Group Is Associated with High Thrombus Burden and Poor Short- and Long-Term Prognosis in ST-Segment Elevation Myocardial Infarction Patients</atitle><jtitle>Medical Principles and Practice</jtitle><addtitle>Med Princ Pract</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>33</volume><issue>5</issue><spage>431</spage><epage>440</epage><pages>431-440</pages><issn>1011-7571</issn><issn>1423-0151</issn><eissn>1423-0151</eissn><abstract>Abstract
Introduction: This study investigated how non-O blood groups relate to thrombus burden (TB) and prognosis in ST-segment elevation myocardial infarction (STEMI) patients, aiming to shed light on their association with thrombotic complications in cardiovascular diseases. Methods: Retrospectively, 1,180 STEMI patients undergoing primary percutaneous coronary intervention were included. The study population was divided into groups according to TB status and the groups were compared in terms of basic clinical characteristics, laboratory parameters and ABO blood group types. In addition, short-term (30 days) and long-term (12 months) clinical outcomes were assessed to evaluate the prognostic implications. Results: The analysis revealed a significant association between non-O blood groups and increased TB in STEMI patients (p = 0.001). Non-O blood group was independently associated with high TB (OR: 1.726, 95% confidence interval [CI]: 1.279–2.330, p < 0.001). Additionally, patients with non-O blood groups had higher short and long-term mortality rates (hazard ratio [HR]: 2.480, 95% CI: 1.361–4.520, p = 0.003; HR: 2.347, 95% CI: 1.433–3.844, p = 0.001; respectively). Conclusions: This study emphasizes the significance of the ABO blood group system in STEMI outcomes, associating non-O blood groups with higher TB and poorer clinical outcomes. While proposing personalized treatment strategies based on blood group status to improve reperfusion interventions and outcomes, additional trials are needed to comprehensively evaluate their impact.
HighlightsNon-O blood groups in ST-segment elevation myocardial infarction (STEMI) patients are linked to higher thrombus burden, suggesting implications for reperfusion interventions.Non-O blood group patients have higher mortality rates, stressing blood group’s importance in STEMI care.Non-O blood group independently predicts high thrombus burden, highlighting its role in STEMI outcomes.This study underscores customizing treatment based on blood group for better outcomes in reperfusion interventions.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>38615658</pmid><doi>10.1159/000538777</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1011-7571 |
| ispartof | Medical Principles and Practice, 2024-10, Vol.33 (5), p.431-440 |
| issn | 1011-7571 1423-0151 1423-0151 |
| language | eng |
| recordid | cdi_crossref_primary_10_1159_000538777 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; PubMed; EZB Electronic Journals Library; Karger Open Access Journals |
| subjects | ABO Blood-Group System Aged Anticoagulants Blood clot Blood clots Blood groups Clinical outcomes Diabetes Disease Female Health aspects Heart attack Heart attacks Humans Male Medical prognosis Medical research Medicine, Experimental Metabolic disorders Middle Aged Mortality Original Paper Patients Percutaneous Coronary Intervention Physiological aspects Prognosis Retrospective Studies ST Elevation Myocardial Infarction - blood ST Elevation Myocardial Infarction - mortality ST Elevation Myocardial Infarction - surgery Statistical analysis Thrombosis Uric acid Veins & arteries |
| title | Non-O Blood Group Is Associated with High Thrombus Burden and Poor Short- and Long-Term Prognosis in ST-Segment Elevation Myocardial Infarction Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T12%3A19%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-O%20Blood%20Group%20Is%20Associated%20with%20High%20Thrombus%20Burden%20and%20Poor%20Short-%20and%20Long-Term%20Prognosis%20in%20ST-Segment%20Elevation%20Myocardial%20Infarction%20Patients&rft.jtitle=Medical%20Principles%20and%20Practice&rft.au=Toprak,%20Kenan&rft.date=2024-10-01&rft.volume=33&rft.issue=5&rft.spage=431&rft.epage=440&rft.pages=431-440&rft.issn=1011-7571&rft.eissn=1423-0151&rft_id=info:doi/10.1159/000538777&rft_dat=%3Cgale_cross%3EA811729190%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3114767435&rft_id=info:pmid/38615658&rft_galeid=A811729190&rfr_iscdi=true |